Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Surgical Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Laparoscopic colectomy.Ann Surg. 1992; 216: 703-707
- Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial.Lancet. 2002; 359: 2224-2229
- Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial.Lancet Oncol. 2009; 10: 44-52
- A comparison of laparoscopically assisted and open colectomy for colon cancer.N Engl J Med. 2004; 350: 2050-2059
- Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial.Ann Surg. 2007; 246 ([discussion: 662-4]): 655-662
- Laparoscopic rectal cancer surgery: where do we stand?.World J Gastroenterol. 2012; 18: 6747-6755
- Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial.Lancet. 2005; 365: 1718-1726
- Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial.Lancet Oncol. 2013; 14: 210-218
- Effect of laparoscopic-assisted resection vs open resection of stage ii or iii rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial.JAMA. 2015; 314: 1346-1355
- Disease-free survival and local recurrence for laparoscopic resection compared with open resection of stage II to III rectal cancer: follow-up results of the ACOSOG Z6051 randomized controlled trial.Ann Surg. 2019; 269: 589-595
- Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial.JAMA. 2015; 314: 1356-1363
- Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial.Lancet Oncol. 2010; 11: 637-645
- Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical Trial.JAMA. 2017; 318: 1569-1580
- Robot-assisted versus laparoscopic surgery for rectal cancer: a phase II open label prospective randomized controlled trial.Ann Surg. 2018; 267: 243-251
- Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.N Engl J Med. 2001; 345: 638-646
- Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial.Lancet Oncol. 2011; 12: 575-582
- Preoperative versus postoperative chemoradiotherapy for rectal cancer.N Engl J Med. 2004; 351: 1731-1740
- Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.J Clin Oncol. 2012; 30: 1926-1933
- Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.J Clin Oncol. 2012; 30: 3827-3833
- Tumour regression after radiotherapy for rectal cancer - Results from the randomised Stockholm III trial.Radiother Oncol. 2019; 135: 178-186
- Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial.Lancet Oncol. 2017; 18: 336-346
- Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.Lancet Oncol. 2021; 22: 29-42
- Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.Lancet Oncol. 2015; 16: 957-966
- Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.Lancet Oncol. 2021; 22: 702-715
- Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results.Ann Surg. 2004; 240 ([discussion: 717-8]): 711-717
- Organ preservation among patients with clinically node-positive rectal cancer: is it really more dangerous?.Dis Colon Rectum. 2019; 62: 675-683
- Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.Lancet Gastroenterol Hepatol. 2020; 5: 465-474
- Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study.Lancet. 2018; 391: 2537-2545
- Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy.J Clin Oncol. 2022; 40: 2546-2556
- Pure natural orifice transluminal endoscopic surgery for rectal cancer: Ta-TME and CME without abdominal assistance.Asian J Surg. 2019; 42: 450-457
- initial clinical experience with single-port robotic transanal total mesorectal excision (SP rTaTME).Tech Coloproctol. 2021; 25: 721-726
- "Down-to-Up" transanal NOTES Total mesorectal excision for rectal cancer: Preliminary series of 9 patients.J Minim Access Surg. 2014; 10: 144-150
- [Total mesorectal excision in rectal cancer management: laparoscopic or transanal?].Khirurgiia (Mosk). 2016; : 37-44
- Comparison of pathological outcomes after transanal versus laparoscopic total mesorectal excision: a prospective study using data from randomized control trial.Surg Endosc. 2020; 34: 3956-3962
- COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer.Surg Endosc. 2016; 30: 3210-3215
- Study protocol for a multicenter prospective controlled and randomized trial of transanal total mesorectal excision versus laparoscopic low anterior resection in rectal cancer.Int J Colorectal Dis. 2018; 33: 649-655
Article info
Publication history
Published online: November 03, 2022
Footnotes
Funding: None.
Disclosure: The authors have nothing to disclose.
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
